US Patent Issued to REGENERON PHARMACEUTICALS on June 3 for "Method of using a genetically modified mouse that expresses human albumin" (New York, Pennsylvania Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,317,874, issued on June 3, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Method of using a genetically modified mouse that expresses human albumin" was invented by Qing Fang (Chappaqua, N.Y.), Chia-Jen Siao (New York), Dan Chalothorn (New York), KehDih Lai (Yardley, Pa.), Leah Sabin (Goldens Bridge, N.Y.), Rachel Sattler (New York), Brian Zambrowicz (Sleepy Hollow, N.Y.) and Lori Morton (Chappaqua, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Non-human animal genomes, non-human animal cells, and non-human animals comprising a humanized albumin (ALB) locus and methods of making and using such non-human animal genomes, non-human...